Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments. (Q38779494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26989919%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26989919%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26989919%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

published in

Acta Neuropsychiatrica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26989919%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26989919%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26989919%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

193-209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26989919%20AND%20SRC:MED&resulttype=core&format=json

Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Adrenocortical hyperactivity in depression: Effects of agitation, delusions, melancholia, and other illness variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The validity of the dexamethasone suppression test as a marker for endogenous depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The relevance of the in- versus outpatient status for studies on HPA-axis in depression: spontaneous hypercortisolism is a feature of major depressed inpatients and not of major depression per se.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Biological heterogeneity of melancholia: results of pattern recognition methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortisol circadian rhythm alterations in psychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

DST studies in psychotic depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Hypothalamic-pituitary-adrenal axis function in patients with chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Corticotropin-releasing factor binding sites in cortex of depressed suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Evidence against changes in corticotroph CRF receptors in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Mineralocorticoid receptor function in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Rapid reversal of psychotic depression using mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Glucocorticoids and the genesis of depressive illness. A psychobiological model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Serotonin, stress and corticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The Variations of Plasma Corticosterone/Cortisol Ratios Following ACTH Stimulation or Dexamethasone Administration in Normal Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortisol is secreted episodically by normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Dissociation between pituitary and adrenal suppression to dexamethasone in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortisol suppression by dexamethasone in the healthy elderly: effects of age, dexamethasone levels, and cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The perfect time to be stressed: a differential modulation of human memory by stress applied in the morning or in the afternoon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Arousal and cortisol interact in modulating memory consolidation in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortisol and memory retrieval in humans: influence of emotional valence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Acute stress enhances memory for emotional words, but impairs memory for neutral words

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Acute cortisone administration impairs retrieval of long-term declarative memory in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Decreased memory performance in healthy humans induced by stress-level cortisol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Effects of hydrocortisone administration on cognitive function in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Dose-dependent effects of hydrocortisone on memory in human males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Dexamethasone increases plasma free dopamine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

A corticosteroid/dopamine hypothesis for psychotic depression and related states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

PET measurement of the influence of corticosteroids on serotonin-1A receptor number

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Lack of effect of a single dose of hydrocortisone on serotonin(1A) receptors in recovered depressed patients measured by positron emission tomography with [11C]WAY-100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

5-Hydroxytryptamine receptor function in humans is reduced by acute administration of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Effects of dexamethasone on neuroendocrine and psychological responses to L-tryptophan infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Corticosteroid-serotonin interactions in depression: a review of the human evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Mood and neuropsychological function in depression: the role of corticosteroids and serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Antiglucocorticoid treatment of depression: double-blind ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortisol secretion in endogenous depression. II. Time-related functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Reduced cortisol latency in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Pituitary-adrenal axis rhythm disturbances in psychiatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Twenty-four-hour ACTH and cortisol pulsatility in depressed women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Depression, Stress and the Adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The glucocorticoid receptor: part of the solution or part of the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Do antidepressants regulate how cortisol affects the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortisol secretion in endogenous depression. I. Basal plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Thyroid and adrenal axis in major depression: a controlled study in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Pituitary size in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Dehydroepiandrosterone treatment of midlife dysthymia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

An open label trial of C-1073 (mifepristone) for psychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Treatment of depression with antiglucocorticoid drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Glucocorticoid receptor function in vitro in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Future therapeutic targets in mood disorders: the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cytokines: abnormalities in major depression and implications for pharmacological treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Hypercortisolemic depression is associated with increased intra-abdominal fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Neurosteroids, brain damage, and mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Phenotypic plasticity of CRF neurons during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The age of dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Fortnighly review. Stress, the brain, and mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Gene regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Pathways to the secretion of adrenocorticotropin: a view from the portal*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

21 January 2018

Neuronal birth and death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Neurocognitive impairment in drug-free patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Memory disturbances and dexamethasone suppression test in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

A molecular framework for the actions of glucocorticoid hormones in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The DST as a predictor of outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The use of ketoconazole as an inhibitor of steroid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

Pituitary volume in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X

The contribution of hypercortisolaemia to the cognitive decline of geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2006.00152.X